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ABSTRACT 
MAGNETIC TARGETED DRUG DELIVERY SYSTEM IN GENE THERAPY 
 
by 
Weilong Lu 
Drug delivery system is a method to transport the drug of the required amount accurately 
to the targeted diseased part. Recently, the concept of Magnetic Targeted Drug Delivery 
System (MTDDS), based upon magnetic particles under the action of an external 
magnetic field, exhibits considerable potential for a wide range of medical applications. 
Gene therapy is the insertion of genes into an individual's cells and tissues to treat 
diseases. As the recombinant virus vector has many limits and problems, more studies 
turn to the nonvirus vectors, which have transfection efficiency and low cytotoxicity. 
PLLA(poly(L lactic acid)) can be biodegradable and has high biocompatibility. PLLA is 
already used in functional biomedical materials, including functional gene vectors. 
This thesis covers the synthesis and characterization of  superparamagnetic iron 
oxide nanoparticles and summarizes the research process of polymeric coating  as a 
function of gene vectors. Nuclear magnetic resonance technology is used to identify the 
structure of the polymer step by step. At last, the use of PLLA(poly(L lactic acid)) in 
gene therapy is combined with the MTDDS. The PEI-PLLA-SS-PLLA-PEI was 
successfully made and could be applied for fabrication of superparamagnetic iron oxide 
nanoparticles as polymeric coatings at nanometer scale.         
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CHAPTER 1  
INTRODUCTION 
Targeted Drug Delivery System and Gene Therapy 
Nanotechnology for diagnosis, treatment and monitoring diseases is a fast growing field in 
biomedical research, in which drug delivery system is the most promising area [1]. Drug 
delivery system is a method to transport the drug of the required amount accurately to the 
targeted diseased part, so that the drug efficiency is enhanced and the side effect is reduced. 
Recently, the concept of Magnetic Targeted Drug Delivery System (MTDDS), based on 
magnetic particles under the action of an external magnetic field, has shown considerable 
promise for a wide range of medical applications including cancer therapy, gene therapy, 
blood detoxification, and radiation treatment.  
 Compared with the traditional methods, MTDDS has the advantages of 
quick-impact, high efficiency, reduction in toxicity as well as minimizing some adverse 
side effects in the non-target region when the drug is concentrated in the specific diseased 
part [2]. MTDDS technology has significantly evolved since the early 1970s; two most 
important aspects are the use of superparamagnetic iron oxide nanoparticles (SPIONs) and 
the utilization of external magnetic fields. Firstly, biocompatible superparamagnetic iron 
oxide nanoparticles (SPIONs) with proper characteristics, including colloidal stability, 
shape, size, size distribution, surface charge and toxicity, are the best nanoparticles among 
all types for various biomedical applications. Secondly, in this technology, one of the most 
significant issues is the methodology to guide and locate the transport of SPIONs. There 
are two limitations. One is that the high blood flow velocity in the human arteries has  
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negative influence on the accumulation of drug-filled nanoparticles. Another main 
problem for translating fundamental research into clinical practice is the depth the 
magnetic fields can reach at a given target site [3]. Therefore, the optimization of the 
external magnetic field and the improvement of the magnetic properties of nanoparticles 
are the key to satisfy the requirements of MTDDS for the control of transport of the 
SPIONs in the human body. Most of the experiments that have been performed in the 
literature are related to the improvement of the coating on the magnetic carriers and the 
method of synthesis in targeting. Figure 1.1 describes the processes of preparation of 
magnetic particles for drug delivery. 
 
 
Figure 1.1 Processes of magnetic particles preparation for drug delivery. Source: [4] 
 
Coating of SPIONs with polymers used for drug delivery is the most commonly 
used way, because the surface of polymers provides better physical and chemical 
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properties [4]. Moreover, the polymer shell of SPIONs has the advantage of good 
dispersion, high stability against oxidation and low toxicity. Polymer coatings are widely 
used in gene therapy for targeted drug delivery. 
 Gene therapy is the insertion of genes into individual cells and tissues to treat 
diseases, such as hereditary diseases where deleterious mutant alleles are replaced with 
those that are functional. For instance, using the specific gene carriers to transport 
treatment materials such as genes and nucleic acid drugs into the targeted cells in order to 
produce bioactivators to cure the disease due to the loss of genes [5] is a good example. The 
supporter of the gene is DNA which is hard to get access into the cells and is easy to be 
degraded in the blood and cells. Thus, a specific carrier must be used to transport the DNA 
to targeted area of the human body. Normally, the carriers of the DNA can be classified 
into virus vector and non-virus vector. As the recombinant virus vector has limitations and 
problems, studies are being conducted on the nonvirus vector, which have transfection 
efficiency and low cytotoxicity. PLLA(poly(L lactic acid)) can be biodegradable and has 
high biocompatibility. PLLA is already being utilized in functional biomaterials, including 
functional gene vectors. 
This thesis covers the synthesis and characteristics of  SPIONs and summarizes the 
research that is focused on the process of coating polymers to functionalize gene vectors. 
NMR (Nuclear Magnetic Resonance) spectroscopy has been used to identify the structure 
of the polymer step by step.  
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CHAPTER 2  
 METHOD AND  CHARCTERISTICS 
2.1 Synthesis of SPIONs 
In the field of implant-assisted magnetic drug targeting, magnetic nanoparticles (NPs) such 
as octahedral magnetite NPs are always synthesized, silanized, and attached covalently to 
tPA (tissue plasmonigen activator). It is known that the NPs can be targeted accurately to a 
ferromagnetic coil with the coil placed in a magnetic field.  These are based on in vitro 
flow-through studies [6].  
 
 
Figure 2.1  A comparison of published work (to date) on the synthesis of SPIONs by three 
different routes. Source: [7] 
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For the category of SPIONs, magnetite, maghemite and hematite are mainly used. 
Other reported superparamagnetic oxides are ferrites, which are mixed oxides of iron and 
other transition metal ions (for example, Cu, Co, Mn, and Ni). 
There are three most significant published routes for the synthesis of SPIONs as 
presented in Figure 2.1. As for the past chemical routes, one report suggests using ferrous 
salt in the presence of potassium hydroxide to make spherical magnetite NPs by a 
co-precipitation method. Recently, sol-gel methods, in which precipitation from the 
solution as a basic way of crystallization, are being used [7]. In this case, under the 
diffusion from the solution to the surfaces, the nuclei can grow uniformly. However, due to 
the Oswald ripening, large uniform crystals will form through crystal growth by the 
dissolution of small crystallites. Besides, the aggregation of small crystallites through 
coalescence may also lead to large uniform particles.  
The method of using the addition of base to an aqueous solution of ferrous and 
ferric ions in a 1:2 stoichiometry to make a black precipitate of spherical magnetite NPs of 
uniform sizes under an oxygen free environment is the most common one [8]. Compared 
with this method, another method which produces larger nanoparticles is reported recently 
by controlling the ratio of ferrous and hydroxide ions. 
In order to produce sub nanometer size SPIONs, the most important factor is to 
control the crystal growth step during co-precipitation. The micro-emulsion method is an 
alternative and more controlled method compared with another method that uses 
surfactants. 
A recent breakthrough in the aspect of SPION synthesis is the sonochemical routes, 
in which the formation and growth of nuclei and the implosive collapse of bubbles are 
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created at very high temperatures [9]. Another method called electrochemical deposition 
under oxidized condition has also been used for the synthesis of SPIONs. Both the methods 
cannot produce large scale synthesis. In order to solve this problem, using the 
hydrothermal method by microwaves can scale up the size of SPIONs. Besides, from 
earlier studies, bacteria have been used in the biomimetic synthesis of SPIONs. 
2.2 Shape and Size  
The biodistribution of non-spherical and rod shaped nanoparticles must be studied when 
doing research on the effects of nanoparticles on biodistribution. From some old reports, it 
is shown that anisotropically shaped nanoparticles can avoid biolimitation better than 
spherical nanoparticles [10]. The ratio of in vivo blood circulation time of anisotropic 
nanostructures to spherical nanoparticles has been proved to relate to the increase in the 
length-to-width aspect ratio of the nanostructure. Also, the high aspect ratio shaped 
magnetic nanoparticles are shown to increase the blood circulation times over the spherical 
counterparts in vivo. Detailed research is needed to understand what aspect ratios yield 
most dramatic influence in the study of nanoparticles pharmacokinetics. 
The size and size distribution play very important roles in the application of 
SPIONs. Mahmoudi et al. [11] have investigated the effects of the applied magnetic field 
on the SPIONs of various sizes using a Multiphysics finite element model in a simulated 
blood vessel. In this case, a 2D model triangular mesh consisting of a blood vessel, 1 cm in 
width, tissue, 1 cm in width, and an external magnet are used. From Figure 2.2A, the fluid 
flows from the left side to the right side. In order to make different sizes and shapes of 
SPIONs, various synthesis parameters were used. From Figure 2.2, the FEM model can be 
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used to predict both the induced magnetic flux density and fluid velocity fields by solving 
coupled Maxwell and Navier-Stokes equations. It is also shown that the velocity field 
fluctuations (flow turbulence) and amplitude (peak velocity) are affected by the strength of 
the applied magnetic field and magnetic properties of the SPIONs. Interaction exists 
between these parameters in determining the shape and amplitude of the velocity field. 
Less fluctuation and higher amplitude of the velocity field are suggested by the author, 
which is preferable to facilitate the drug delivery, especially in the direction normal to the 
tissue. 
It has been proved that the magnetic dipole-dipole interactions in SPIONs are 
efficiently decreased by the fact that they scale as r
6
, where, r is the particle radius. One 
advantage was reported that the saturation magnetization and size of SPIONs are 
correlated, as the surface curvature changes with size linearly, by Varanda et al. [12]. 
Another important advantage is their higher effective surface (easier attachment of ligands), 
increased tissular diffusion and lower sedimentation rates (i.e., high stability in suspension) 
when the used nanoparticles are smaller than 100nm. In order to escape from the 
reticuloendothelial system, the size of the particles must be smaller than 100 nm. They 
should remain in the circulation system when the injection is done and can pass through the 
capillary systems of organs and tissues without vessel embolism. In addition, the stable 
permeability and retention effect are affected by the size of the particle. For example, 
particles larger than 10 nm can penetrate the endothelium at pathological conditions such 
as tumour infiltration but cannot penetrate in physiological conditions. 
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Figure 2.2  ( A ) 2-D geometry and finite element mesh model of a blood vessel under a 
permanent (static) magnetic field for drug delivery. The (B) x is velocity of the ferrofluid 
containing SPIONs with various sizes. Results are presented for the observation point 
shown in (A). Source: [11] 
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Figure 2.2 The (B) x and (C) y are velocities of the ferrofluid containing SPIONs with 
various sizes. Results are presented for the observation point shown in (A). Samples are 
herein referred to as S(x)M(x), where, S is the stirring rate and M is the NaOH molarity. (D) 
contour lines of magnetic flux density and ferrofluid velocity surface contours in the blood 
vessel model (note: results are shown for t = 1 s for S(12,600)M(1,1); at the observation 
point marked in (A), the value of magnetic flux density is 27.7 mT. Source: [11] 
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The sizes of SPIONs are measured either in dry state or in suspension by many 
different ways. However, in the application, the size in dry state is more important because 
of the solvation shell around the SPIONs. The aggregation behavior is affected by the 
drying step. Dynamic light scattering (DLS), transmission electron microscopy (TEM), 
Scherrer analysis of X-ray diffractograms (XRD) and extended X-ray absorption fine 
structure (EXAFS) are used to investigate the size of the nanoparticles. It is the DLS 
technology which determines the size of the particles in suspension while other methods 
determine the crystallite size in the dry state. The DLS technology is based on volume, 
intensity and number distribution and Scherrer analysis of XRD is based on the broadening 
of the diffraction peak. The most powerful technique is TEM which gives information on 
both the core-shell structure and the size distribution by the difference in electron density 
of core and shell materials, so that it can determine the crystallite and sizes of nanoparticles 
and their morphology. 
After the drug-loaded nanoparticles are injected into the human bloodstream, the 
three most important parameters are the size, size distribution and surface charge. The size 
of the nanoparticles should be above 200 nm or below 10 nm since other sizes will cause 
the particles' uptake by the RES. As for the behavior of injected nanoparticles, the 
biodistribution and the surface charge of SPIONs determine the colloidal stability due to 
the nature and behavior of the surface groups in solution at a certain pH in the presence of 
an electrolyte. 
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2.3 Toxicity 
Many well known examples of the use of SPIONs in biomedical applications have been 
reported including drug delivery, cellular labeling/cell separation, tissue repair, magnetic 
resonance imaging, magnetic hyperthermia and magnetofection. Toxicity of the SPIONs 
and the individual parts must be investigated to avoid harm to the patient when the 
MTDDS is developed. There are two things that must be taken into consideration when 
evaluating nanoparticle toxicity. One is how the assembled nanoparticle system will 
interact with the body in its functional lifetime; another is how the independent 
components will affect the human body during biodegradation and liver processing [13]. 
Though nanotoxicology is a promising field of research, more experiments are needed to 
investigate the human body's response to the SPIONs. 
2.3.1 Toxicity of SPIONs 
Mahmoudi et al. [11] have explored the cytotoxicity of polymer coated SPIONs with 
different shapes and morphologies including nanospheres, nanorods, nanoworms, 
magnetite colloidal nanocrystal clusters and nanobeads in mouse fiberblast cells and 
human leukemia cells. Few or no toxicity is found in his research. In addition, when the 
toxicity is studied in human lung cancer cell lines, neither DNA damage nor intracellular 
toxicity effects were observed. However, small oxidative DNA lesions were detected. In 
another study by Mahmoudi et al. [14], gas vesicles in SPION-treated cells were observed 
with increased granularity of the cells (Figure 2.3).  
As a result, it showed that the cytotoxicity may lead to the autophagy. Since large 
amount of protein absorption exists on the surface of SPIONs, the in vitro cytotoxicity 
studies can encounter a great deal of error. Modifications have been made in the method 
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that uses cell medium to introduce the SPIONs and keeping the solution in contact for a 
period of 24h in order to create a stable protein corona on the surface of the SPIONs [15]. 
As a consequence, reliable and exact cytotoxicity results were obtained. 
 
 
                                                        Gas vehicles and SPIONs 
Figure 2.3   Optical microscopy (800X) of dyed L929 cells for (A) control, (B) cells 
containing 800 mM (millimolar) uncoated SPIONs after a 72h interaction with cells 
showing the existence of gas vehicles. (C) TEM images of SPIONs-treated cells showing 
gas vehicles.Source: [14] 
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After the medium was replaced with a fresh one, the SPIONs obtained were used for 
toxicity assays. Since the nanoparticles can lead to significant changes in the cell medium, 
namely denaturation of proteins, the conventional in vitro examination methods contain 
large errors compared to the modified method. In this case, the toxicity of SPIONs can be 
decreased by this modified method. 
2.3.2 Protein-NP Interaction 
Having been developed intensively for a long time, the study of the interactions between 
nanomaterials and proteins becomes very important in the medical application of 
nanoparticles. Proteins can be adsorbed or associated in a biological fluid which will have 
significant influence on the biological, biochemical and cellular behavior. It is well known 
that the nanoparticle-protein interaction plays a very important role in defining the toxicity 
of nanoparticles [16]. In order to foresee biological injuries caused by changes such as 
fibrillation, the unavoidable changes in the protein configurations should be probed. It is 
the SPION-protein interaction that causes this change. What is more, a new immune 
response will take place followed by the denaturation of the protein after interaction with 
the SPIONs due to the exposure of new antigenic sites. In order to study the interactions, 
there are three normal ways including size-exclusion chromatography (SEC), surface 
plasmon resonance (SPR) and isothermal titration calorimetry (ITC). ITC and SEC studies 
are more related with the affinity and stoichiometry of protein bonded to particles, SPR 
gives the rates of protein association and dissociation. 
For the interaction between the large numbers of potential proteins, there exists one 
problem which is to find a way that has the capability to measure such interactions. One 
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method has been introduced to overcome this problem using an interaction analysis 
platform based on a highly parallel and sensitive microfluidic affinity assay [17]. 
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CHAPTER 3  
POLYMER COATING 
Although the unmodified SPIONs are stable in high and low pH solutions after synthesis, 
they need to be coated before using them in vivo study. Polymers and small organic 
molecules are most commonly used materials for coating of MNPs for drug delivery, as 
demonstrated in the several following functions: (1) enhance the stability of nanoparticles 
against oxidation, (2) chemical handles for the conjugation of drug molecules, targeting 
ligands, and reporter moieties and (3) limit non-specific cell interactions. Additionally, it 
was found surface functionalization plays the key role in nanoparticle toxicity. In order to 
enhance SPION pharmacokinetics, endosomal release, and tailored drug loading and 
release behaviors, polymeric coatings have been widely engineered including PEG, 
dextran, chitosan, PEI, and phospholipid. 
 
Figure 3.1  Illustration depicting the assembly of polymers onto the surface of magnetic 
nanoparticle cores. Source: [18] 
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There are many  approaches which can be used to build SPION coating such as in 
situ coating, post-synthesis adsorption and post-synthesis end grafting [18] (Figure 3.1). In 
situ and post synthesis modification with copolymers and polysaccharides lead to coatings 
that uniformly encapsulate cores.  
Reshmi et al. made a preparation of composite colloidal core/shell nanoparticles, 
which are made of magnetic core (carbonyl iron) and biodegradable polymeric shell 
(cellulose acetate hydrogen phthalate) [19]. During the biodegradation of the polymeric 
shell, it could transport and release the drug. 
 Magnetic nanoparticles tend to aggregate because of the strong magnetic 
dipole-dipole attractions between particles. Dextran and chitosan are usually coated on the 
surface of the MNPs in order to avoid the aggregation [20, 21].  
Dextran is a branched polysaccharide consisting of glucose subunits which can be 
used to prepare with sizes ranging from 10 to 150kDa (1 kDa = 1000 molecules). It has the 
properties of biocompatibility and polar interactions (chelation and hydrogen bonding) that 
make dextran a high affinity for the wide use in iron oxide SPION coatings. In 1982, 
Molday and Mackenzie first described the dextran coatings prepared by in situ techniques 
[22]. Since then, many different forms of dextran polymers have been used such as 
carboxydextran and carboxymethyl dextran. Conventional dextran coatings are based on 
hydrogen bonding, which makes the polymer susceptible to detachment. However, after 
using epichlohydrin and ammonia, forming a CLIO (cross-linked iron oxide (CLIO)-NH2), 
the dextran polymers have been crosslinked due to the SPION attachment [23]. In addition, 
their use in clinical setting becomes unlikely because of the use of epichlohydrin and the 
inability to degrade and clear from the body. 
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  Recently, chitosan is becoming more and more popular in drug delivery due to its 
nontoxic, biocompatible and bioabsorbable properties. It is a cationic, hydrophlilic 
polymer that has large abundance in nature, and ease of functionalization. In the past, 
chitosan and its derivatives have been used to make polymeric nanoparticles through 
electrostatic complexation with nucleic acids and different pharmaceutical processes [24]. 
Different from dextran coatings, the chitosan coatings are produced by physically 
adsorbing chitosan onto oleic acid-coated nanoparticles making spherically shaped 
SPIONs (15 nm diameter) [25]. Chitosan can be used as genetic materials for the 
preparation of gene delivery carrier, even when used as a SPION coating because of its 
cationic nature. The SPIONs serve to enhance the gene transfection. For example, Kumar 
et al. reported chitosan coating on Fe203 MNPs [26]. This technology would constitute a 
useful tool for gene/drug delivery in vivo due to the safe transport and concentration in 
targeted area in the body. In addition, when the drugs are modified with antibodies, protein, 
or ligand, the in vitro drug delivery can be improved. For the in vivo study, before coating 
with chitosan, Fe203 MNPs were synthesized in aqueous medium without surfactants; then 
they were conjugated with plasmid DNA expressing enhanced green fluorescent protein 
(EGFP). The aeration oxidized the colloidal magnetite suspensions and the Fe203 MNPs 
formed. Besides its bioadsorbtive properties, chitosan can be used for SPION 
functionalization with targeting, imaging, and therapeutic agents due to the amino and 
hydroxyl radicals.  
Another water soluble cationic polymer coating material is polyethyleneimine 
(PEI). PEI can be both linear and branched forms and has been used for gene delivery for a  
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long time due to its ability to synthesize with DNA, accelerate endosomal release, and lead 
to intracellular trafficking of the cargo into the nucleus [27]. 
Abdalla et al. performed some research on the drug loading efficiency of 
polylactide (PLLA) and poly (1-lactide acid- co-gylocolide) (PLGA) polymeric systems of 
many different molecular weights [28]. It is shown that the molecular weight of the 
polymer has significant influence on the capacity of the drug loading on the polymer 
surface.  
Copolymers have been developed because of their distinct functionalities from 
their components. The advantages of these copolymers can be applied to SPION coatings. 
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CHAPTER 4  
GENE VECTORS 
Gene therapy is the insertion of genes into individual cells and tissues to treat diseases such 
as hereditary diseases where deleterious mutant alleles are replaced with functional ones. 
For instance, using the specific gene carriers to transport treatment materials such as genes 
and nucleic acid drugs into the targeted cells in order to produce bioactivators to cue the 
disease due to the loss of genes [5] is a good example. The supporter of the gene is DNA 
which is hard to get access into the cells and is easy to be degraded in the blood and cells. 
Thus, a specific carrier must be used to transport the DNA to targeted area of the human 
body. Normally, the carriers of the DNA can be classified into virus vector and non-virus 
vector. 
4.1 Gene Vectors 
4.1.1 Virus Gene Vectors 
Virus have been evolved for billions of years and they have their own strategy to intrude 
into the cells. With the application of this strategy, people use virus as vector for gene 
therapy, remove the pathogenetic part of the gene and plant healing gene into the virus 
vector so that it can access into the cells and express related proteins. Among all the virus 
vectors, adenovirus and retrovirus are used frequently. But virus vector also has safety 
problems. As most of the virus vectors are with relatively high immunogenicity, human 
immune system will identify the virus and generate large amounts of antibodies which 
makes the virus and the DNA along with it both be phagocytosed and degraded at the same 
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time [29]. The selected cloning is defective, so the cloning protein will trigger the human 
immune system and cause damage to target cells, which deceases the transfected cells and 
then shortens the target cells’ duration to a certain extent [30,31]. 
4.1.2 Non-virus Gene Vectors 
As non-viral gene vectors have shown multiple potential advantages in the aspects of 
experiment and treatment, more and more researchers choose non-viral gene vectors for 
genetic therapy research. Thus more and more non-viral gene vectors appear, such as 
liposome or liposome complex vectors, cationic polyphosphate vectors, naked DNA, 
nanometer materials, human artificial chromosome and so on [32]. 
(1) Liposome or liposome complex vectors     
Liposome is enclosed particles with bilayer structure. Cationic liposome has a 
relatively accurate molecular structure and its basic structure is hydrophobic chain attached 
to cationic head group. Cationic liposome compound can become Cationic liposome/DNA 
compound (Lipoplex) through static electricity self-assembly. Lipoplex gets into cells 
through endocytosis, thus releases the gene which it loads to complete transfection. 
Cationic liposome compound will not generate immune response and has advantages such 
as easily prepared liposome and stabilized storage. It is widely used in genetic therapy 
because of all these qualities. Also, it is recently considered as one of the supplies for 
supermolecule drug delivery system research. Now some cationic liposome compounds 
with excellent performance such as DOPE, DOTMA, Lipo2000 have been 
commercialized. 
  But, liposome complex is formed according to spontaneous dynamics, which 
makes it hard to control. So the cationic liposome that is obtained is usually a compound of 
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multiple structures. The physiochemical stability of cationic liposome compound in body 
fluid is not good enough and the compound is easy to be cleared and exit body cycles. Most 
of the cationic liposome/genetic compound is hard to be released under control, the 
cytotoxicity is relatively high and it is hard to make it on a large scale [33].  
(2) Cationic polyphosphate carrier 
Through the electrostatic combined action, cationic polyphosphate carrier, together 
with gene, can form a composite particle with appropriate grain size and the ability of 
transfection. This particle enters cell by endocytosis and moves further into nucleus to 
integrate with the gene. Then, in order to accomplish treatment by expression of target 
gene, PEI is a very effective gene transfer vector. Amphipathic triblock gene vector is the 
hottest research area of gene vectors. 
(3) Naked DNA  
Attach target gene to the plasmid to be expressed and inject this reorganized naked 
DNA into the cells directly to express without relying on mediation of other materials. 
(4) New nanometer materials gene vectors 
Nanometer material gene vectors can combine with the plasmid to be expressed 
very well and accomplish local gene transfection and expression within the body and play 
its relevant effect. 
(5) Human artificial chromosome. 
Since the traditional virus carrier has immunogenicity and will cause genetic 
mutation after inserting host genomes, it is difficult to achieve safety and efficiency 
transfection results. Thus people consider building bionic artificial gene for the gene 
transfection, which will become a reasonable gene vector in the future. 
22 
 
 
4.2 Linear PLLA Amphiphilic Cationic Gene Vector  
The high polymer material, poly-lactic acid (PLA) which is made by lactic acid 
polycondensation not only has excellent mechanical strength and chemical stability, but 
also has good biocompatibility, absorbability and environmental degradability [34]. 
Therefore, PLA is a very promising medical physiological material and, generally, 
environmentally friendly high polymer material. It is also one of the key areas for 
international biodegraded materials research. The linear polylactic acid cationic genetic 
vector that will be introduced is synthetized by L-Lactic Acid and D-D-Lactide. Linear 
PLLA amphipathic triblock gene vector has become a new candidate in macromolecule 
genetic vectors with its excellent functions and biodegradability.  
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CHAPTER 5  
EXPERIMENTAL RESULTS AND DISCUSSION 
Nuclear magnetic resonance (NMR) is a physical phenomenon in which magnetic nuclei in 
a magnetic field absorb and re-emit electromagnetic radiation . This energy is at a specific 
resonance frequency which depends on the strength of the magnetic field and the magnetic 
properties of the isotope of the atoms; in practical applications, the frequency is similar to 
VHF (Very high frequency) and UHF (Ultra high frequency) television broadcasts 
(60--1000 MHz). NMR enables the observation of specific quantum mechanical magnetic 
properties of the atomic nucleus. Many scientific techniques exploit NMR phenomena to 
study molecular physics, crystals, and non-crystalline materials through NMR 
spectroscopy. NMR is also routinely used in advanced medical imaging techniques, such 
as in magnetic resonance imaging (MRI) [35]. 
In this chapter, the experimental methods used in this research will be introduced. 
All the samples were made by Ziqian Fan, a Master’s degree candidate in the lab. Fan used 
HEDS (Hydroxyethyl Disulfide) to initiate the ring-opening polymerization to form 
PLLA-SS-PLLA. Then, cationic groups were attached to the PLLA-SS-PLLA to form 
embedded zone molecules PEI-PLLA-SS-PLLA-PEI.  
In this work, NMR spectroscopy was utilized to investigate the structure of the 
polymers in every polymerization step. This chapter focuses on the results of NMR 
spectroscopy. 
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5.1 Purification of Reagent 
The reagents were purified to avoid the influence of impurities on the experimental results.  
In Figure 5.1, the NMR spectra of lactide, after purification, are shown from region 
0 to 7 PPM. Two peaks at 1.68 and four peaks at 5.05 are observed. It can be seen clearly 
that the two peaks represent the a-H on the methyl of lactide at 1.68ppm. Also, it can be 
seen that the four peaks at 5.05 PPM represent the b-H on the ring of lactide. 
 
 
Figure 5.1 NMR spectra of lactide after purification .  
 
Reduced pressure distillation was used to purify the HEDS. The purified HEDS are 
divided into three parts. In Figure 5.2, the NMR spectra of purified HEDS are shown. It can 
be seen that the first cut fraction and the second cut fraction are the same HEDS. 
 
Figure 5.2 NMR spectra of HEDS after purification. 
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5.2 Characterization of PLLA-SS-PLLA 
In 2001, Hedrick [36] has reported synthetizing polylactic acid by using DMAP 
(Dimethylaminopurine) to catalyze ring-opening polymerization of lactides. This catalyst 
system requires mild condition. It can react successfully under room temperature. It will 
not have racemization and chain transfer reactions during the polymerization process. It 
can form structured linear polymer. Hou [37] and others have synthetized PLLA-SS-PLLA, 
which has a more narrow molecular weight distribution and the reaction can be easily 
controlled. 
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Figure 5.3   The principle of ring-opening polymerization of lactide catalyzed by DMAP. 
 
Another advantage of using DMAP as the catalyst is no metals will be left thus 
avoiding their influence on the performance of polylactic acid. 
For the macromolecules with lipophilic cations, its ability to integrate with DNA 
will be changed due to change in the ratio of hydrophobic chains and hydrophilic chains. 
The DNA will be released after the bond break in the disulfide. 
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Figure 5.4   NMR spectra of PLLA-SS-PLLA. 
 
The H in the chemical formula can be observed in Figure 5.4. Since the chemical 
environment of the b-H is simple, the peak that represents b-H is clearer. The area of other 
peaks can be integrated by setting the area of the b-H peak as a standard. Then the degree of 
polymerization can be calculated through the number of H in the main chain. For instance, 
the area of b-H is 4, the integral quantity of b-H in Figure 5.4 is 39.68. Thus, the polymer is 
PLLA10-SS-PLLA10. 
12 14 16
 plla10-ss-plla10
 plla10.5-ss-plla10.5
 plla8.5-ss-plla8.5
 plla11-ss-plla11
 
Figure 5.5   GPC (Gel permeation chromatography) spectrogram of PLLA-SS-PLLA. 
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In Figure 5.5, it is shown that the polymers with the same molecular weight are 
detected at the same time (via the peaks). The peak for each polymer can be observed in the 
same area, which means that this reaction method is easy to control in a simple 
experimental condition. 
Table 5.1 Important Displacement, Crack and Integration of Figure 5.4 
Number 1 2 3 
Displacement of H 2.9 4.4 5.2 
Crack points of H 3 3 4 
Integral quantity 4(Standard) 4.96 39.68 
Notes HEDS(SS) HEDS(O) PLLA 
 
 
Since polymers remain in the shape of a sphere when dissolved in solvent, the 
methyls of PLLA that are not located in the main chain may interact with each other. As a 
consequence, the integral quantity of methyl-H at 1.6 deviated significantly from the 
theoretical value. 
 
Table 5.2  Molecular Weight of PLLA-SS-PLLA From NMR 
 
Name 
Molecular Weight 
Mn Mw 
PLLA10.5-SS-PLLA10.5 3178 5154 
PLLA10-SS-PLLA10 3034 5111 
PLLA8.5-SS-PLLA8.5 2602 3943 
PLLA11-SS-PLLA11 3322 5360 
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5.3 Characterization of Activated PLLA-SS-PLLA 
Before the reaction with the cationic groups, the hydroxyl groups of polylactic acid must be 
activated. 
In Figure 5.6, the integration quantities of peaks at 7.4 and 8.3 are calculated by 
setting the b-H (four H) next to SS as a standard. The activation degree of the products is 
1.81/4*100%=45.3%, which means 45.3% of terminal hydroxyl groups were connected 
with the activation ester. 
 
 
Figure 5.6   NMR spectra of activated PLLA-SS-PLLA. 
 
Table 5.3 Important Displacement, Crack and Integration of Figure 5.6 
Number 1 2 3 4 5 
Displacement 
of H 
2.9 4.4 5.2 7.4 8.3 
Crack points 
of H 
3 3 4 2 2 
Integral 
quantity 
4(Standard) 4.26 38.76 1.91 1.81 
Notes HEDS(SS) 
HEDS
(O) 
PLLA(Main 
chain) 
Benzene 
ring(NO2) 
O(Benzen
e ring) 
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The integration quantities of peaks at 7.4 and 8.3 were less than 2; it means not all 
the terminal hydroxyl groups were activated. In other words, parts of the terminal hydroxyl 
groups of the PLLA were not activated or fell off after activation. 
5.4  Characterization of PEI-PLLA-SS-PLLA-PEI 
Arborescent cationic molecules have been extensively studied due to their enormous 
ability to combine with genes [38-44]. Among these, the PEI2K can not only combine with 
gene very well, but also has excellent transfection effect. But, its relatively high 
cytotoxicity limits it to be applied as gene vectors [45]. Many studies in the literature 
[46-48] have reported that adding hydrophobic parts to cationic gene vectors can enhance 
its ability to combine with the DNA. Li Yang [49,50] has specially studied the proportion 
of hydrophilic and hydrophobic in PLLA arborescent cationic marcromolecules that can 
affect its ability to combine with the gene. When the hydrophobic chain part is bigger, it 
will help the cationic marcromolecules to combine with the gene. Therefore, Li Yang tried 
to use micromolecule quantized PEI423 as the end of the arborescent cationic group. 
PEI contains amino acid. Stable conjugated molecules of p-nitrophenol can be 
produced through the ammonolysis reaction between the terminal carbonic esters of 
activated PLLA-SS-PLLA and PEI. 
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Figure 5.7   NMR spectra of PEI-PLLA-SS-PLLA-PEI. 
 
Table 5.4  Important Displacement, Crack and Integration of Figure 5.7 
Number     1 2 3 
Displacement of 
H 
2.3-3.1 4.4 5.2 
Crack points of 
H 
3(diffuse) 3 4 
Integral quantity 19.21 4.26(Standard) 33.3 
Notes H(PEI, SS) HEDS PLLA(Main chain) 
 
Because PEI423 is a hyperbranched PEI molecule, its structural uncertainties are 
relatively high. Thus it is hard to speculate its peak location and split situation. We can only 
speculate its magnetic cores when it exists alone in deuterated chloroform and speculate 
the peak of hyperbranched PEI by referring to articles with small molecular NMR spectra. 
Some studies [51] have reported that magnetic nuclear displacement of 
hyperbranched PEI is somewhere between 2.3-3.1 PPM. According to the NMR spectra of 
hyperbranched PEI423 in Figure 5.8, the peaks between 2.3-3.1 contain H PEI and H on 
the disulfide bond.  Because there is no change at the SS bond of the reactants that we use, 
and by comparing the peak of the part connected to acyloxy of the reactant and the product 
  
 
31 
HEDS, we can find that the location and shape of the peak merely change. So using the 
4.26 activated H at the 4.4 of PLLA-SS-PLLA as the standard to do numerical integration 
of other peaks, there are about 19 H between 2.3-3.1, among which 4 H belong to the center 
of polymer PLLA-SS-PLLA near disulfide bond. It indicates that the product contains 
PLLA partially connected to the PEI and a cross-linked macromolecule with the PEI 
connected to two or more PLLA-SS-PLLA.  
Molecules, partially connected with cross-linked macromolecule or more 
PLLA-SS-PLLA, will not affect the cationic groups. With the combination of PEI and 
DNA reduction and the response of the release, this water group has smaller proportion of 
hydrophilic groups and hydrophobic groups, and it is very good for combining DNA with 
cationic macromolecules. When adding a reducing material to the molecules joined with 
the DNA, the disulfide bond at the center of the hydrophobic chain will break into sulfydryl. 
After the disulfide bond break, the proportion of hydrophilic groups and hydrophobic 
groups will increase rapidly, which will cause the pyrolysis of composite microsphere core 
and then the release by combining with DNA at the spherical shell. The ability to combine 
with DNA can assure that these macromolecules have the potential properties as a gene 
vector.  
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Figure 5.8   NMR spectra of PEI423 in CDCl3. 
 
In Figure 5.8, it is shown that the peaks of PEI423 distributed in the range of 2.4 to 
3.0 are diffused. 
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CHAPTER 6  
CONCLUSIONS 
The cationic nature of PEI-PLLA-SS-PLLA-PEI allows complexation with genetic 
materials making it suitable for use as a gene delivery carrier, even when used as a 
polymeric coating on superparamagnetic iron oxide nanoparticles. In addition, these 
superparmanetic iron oxide nanoparticles are used to enhance gene transfection. The NMR 
spectra showed that the PEI-PLLA-SS-PLLA-PEI was successfully made. It can be 
applied for fabrication of SPION as polymeric coating at nanometer scale.  
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